Who invested in Omniose

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$3.0Mraised across 1 round since 2023, from 1 source

Latest round: Grant, $3.0MSept 2023
Investors: 3

See who backed them

The rounds

Sept 2023
Grant$3.0M
Source recorded

Founders and team

From Omniose's own website: 1 founder, 1 on the team.

Representing AstraZenecaFounder

Benjamin MoutierBoard Member

Everyone who backed them

National Institutes of HealthGovernment1round

Arch GrantsGovernment1round

National Institute of Allergy and Infectious DiseasesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Omniose

Who invested in Omniose?

Omniose's investors include National Institutes of Health, Arch Grants and National Institute of Allergy and Infectious Diseases.

How much has Omniose raised?

Omniose has raised $3.0M across 1 round since 2023.

When did Omniose last raise?

Omniose's most recent round was a Grant of $3.0M in Sept 2023.

What was Omniose's biggest round?

Its most recent round, $3.0M in Sept 2023, is also its largest on record.

Who backed Omniose first?

Omniose's first round on record, in Sept 2023, was backed by National Institutes of Health, Arch Grants and National Institute of Allergy and Infectious Diseases.